4530 Hisamitsu Pharmaceutical
- 4225.0
- -52.0-1.22%
Hisamitsu Pharmaceutical News
Hisamitsu Pharmaceutical: Notice of adoption of an open call for the vaccine/novel modality research and development project (public call) by AMED
Hisamitsu Pharmaceutical: Fatuship Fatuship Warmth Faith Z Zixus F Renewal Release Notice
Hisamitsu Pharmaceutical: Notice of commencement of clinical development of HP-3150 (transdermal nonsteroidal pain treatment) in the US
Hisamitsu Pharmaceutical: Introduction of the “Trust Type Employee Shareholding Incentive Plan (E-Ship)”
Hisamitsu Pharmaceutical: [Summary]Consolidated Financial Results for the Second Quarter(Interim Period)of the Fiscal Year Ending February 28, 2025 [Japanese GAAP]
Hisamitsu Pharmaceutical: SAGA Global Research Center Announces Recruiting Collaborative Partners for the Purpose of Open Innovation
Hisamitsu Pharmaceutical: Announcement of the new sale of “Salonpas” 160 sheets “Fatus 5.0” 120 sheets
Hisamitsu Pharmaceutical: [Overview] Consolidated financial statements for the first quarter of the fiscal year ending on February 28, 2025.
Hisamitsu Pharmaceutical: Announcements of individual stocks: Announcement of results for the domestic Phase 2 clinical trial of HP-6050 (transdermal sedative).
Hisamitsu Pharmaceutical: [Postponed] Corporate Governance Report
Hisamitsu Pharmaceutical: Kusuri Pharmaceutical has chosen Mr. Mukai to be the image character for their new TV commercial for Escap. It will start airing nationwide from Saturday, June 8th, 2024 with a focus on morning self-care in the cell.
Hisamitsu Pharmaceutical: Notice of price revisions
Hisamitsu Pharmaceutical: Hisamitsu Pharmaceutical's new “Salonpas” TV-commercial features Alice Hirose as the new image character! “Immediate Attachment Course” version will be on air nationwide from 2024/5/31 (Friday)
Hisamitsu Pharmaceutical: New TV commercial featuring primary palmar hyperhidrosis disease awareness characters will go on air nationwide from 2024/6/1 (Sat)
Hisamitsu Pharmaceutical: Executive personnel
Hisamitsu Pharmaceutical: Salonpas certified as the world's No. 1 sales share brand for 8 consecutive years
Hisamitsu Pharmaceutical: Notice of obtaining “DX certification” as determined by the Ministry of Economy, Trade and Industry
Hisamitsu Pharmaceutical: Independent Officer Notification Form
Hisamitsu Pharmaceutical: Notice of implementation of the “High Fives Project” ~Just the Number of High Fives, the Power to Handle the Future of Saga~
Hisamitsu Pharmaceutical: “Nobi Nobi Salon Ship Fit,” “Nobi Nobi Salon Ship Fit α (odorless),” and “Nobi Nobi Salon Ship Fit H (warm)” renewal release announcement
Analysis
Price Target
No Data
No Data